5th Annual
Clinical Trial
Innovation Summit
Innovation Summit
26 JUNE 2025 | BASEL | ROCHE BUILDING 1
PRESENTED BY
The Clinical Trial Innovation Summit returns to Roche Headquarters in Basel on 26 June 2025!
PanAgora Pharma and Roche are collaborating once again to bring the 5th Annual Clinical Trial Innovation Summit back to Basel this 26 June! This year's conference agenda will explore how life sciences organizations are delivering more patient-centric clinical trials and how digital health technologies (DHTs) are being implemented to improve efficacy measurement, patient recruitment, safety, and drug delivery.
Core themes and topics for the 2025 agenda include:
• Industry Trends and Innovations in Virtual, Hybrid and Decentralized Trials: AI, DHTs, Decentralized Trials, Evolving Role of CRO’s, Global Perspective
• Patient Perspective: Engagement, Involvement, and Applying Learnings at Scale
• Identifying Innovations & Technologies Accelerating Patient-Centric Trials
• Ideas into Action: Keys to Delivering Inclusive Human-Centered Clinical Trials
Join 35+ speakers and 250+ senior-level clinical research, operations, and trial design leaders on 26 June at Roche headquarters in Basel!
Core themes and topics for the 2025 agenda include:
• Industry Trends and Innovations in Virtual, Hybrid and Decentralized Trials: AI, DHTs, Decentralized Trials, Evolving Role of CRO’s, Global Perspective
• Patient Perspective: Engagement, Involvement, and Applying Learnings at Scale
• Identifying Innovations & Technologies Accelerating Patient-Centric Trials
• Ideas into Action: Keys to Delivering Inclusive Human-Centered Clinical Trials
Join 35+ speakers and 250+ senior-level clinical research, operations, and trial design leaders on 26 June at Roche headquarters in Basel!
Location
Date & Time
26 June 2025
08:45-18:00 Local Time (GMT+2)
Apéro to Follow
08:45-18:00 Local Time (GMT+2)
Apéro to Follow
HOST SPONSOR
AGENDA THEMES
1. Industry Trends and Latest Innovations: AI, DHTs, Decentralised Trials
2. Accelerating Patient-Centric Trials: Innovations & Technologies
3. Enhancing Diversity in Clinical Trials: Stakeholder Perspectives
4. Ideas into Action: Delivering Human-Centered Clinical Trials
SPEAKING FACULTY & ADVISORS
Sam Hariry
Global Head, Clinical Innovation
Global Head, Clinical Innovation
NOVARTIS
Léa Proulx
Patient Voice Partner
Patient Voice Partner
ROCHE
Ernst Bos
Global Medical Director
Global Medical Director
ROCHE
Paul Cooper
Personalised Healthcare Strategy Leader
Personalised Healthcare Strategy Leader
ROCHE
Bola Grace
Senior Director, Digital Biomarkers, Real World Data & Analytics
Senior Director, Digital Biomarkers, Real World Data & Analytics
GSK
Scott Askin
Portfolio Innovation Director, Global Clinical Operations
Portfolio Innovation Director, Global Clinical Operations
NOVARTIS
Nadir Ammour
Global Lead, Clinical Innovation & External Partnerships
Global Lead, Clinical Innovation & External Partnerships
SANOFI
Isabela Niculae
Head, Clinical Innovation and Digital Solutions, Global Clinical Operations
Head, Clinical Innovation and Digital Solutions, Global Clinical Operations
UCB
Suki Balendra
Director of Strategic Partnerships
Director of Strategic Partnerships
IMPERIAL COLLEGE HEALTHCARE NHS TRUST
Meri Kay Scott
Associate Vice President, Digital Health R&D
Associate Vice President, Digital Health R&D
ELI LILLY AND COMPANY
Dan Karlin
Chief Medical Officer
Chief Medical Officer
MINDMED
Lauren Sunshine
Director, Product Management, Digital Health
Director, Product Management, Digital Health
BMS
Thomas Boillat
Senior Digital Health Product Lead
Senior Digital Health Product Lead
ROCHE
Joachim Lövin
DCT Specialist
DCT Specialist
NOVO NORDISK
Matteo Lai
Chief Executive Officer
Chief Executive Officer
EMPATICA
Michelle Longmire
CEO & Co-Founder
CEO & Co-Founder
MEDABLE
Sebastian Heinzmann
Global Medical Science Leader, Thoracic Oncology
Global Medical Science Leader, Thoracic Oncology
ROCHE
Marco Rafael
Regulatory Science Policy Leader
Regulatory Science Policy Leader
ROCHE
Steve Bourke
Founder
Founder
PERSONALPULSE
Amri Johnson
Founder
Founder
INCLUSION WINS
Alison Holland
Chief Customer Officer
Chief Customer Officer
MEDABLE
Aude Clement
Pharma Development Regulatory Program Management Leader
Pharma Development Regulatory Program Management Leader
ROCHE
Thomas Brookland
Lead, European Data and AI Regulatory Policy
Lead, European Data and AI Regulatory Policy
ROCHE
Thierry Lave
R&D Academy and Faculty Lead
R&D Academy and Faculty Lead
ROCHE
Lorcan Walsh
Head, Digital Endpoint Capability Centre, Development
Head, Digital Endpoint Capability Centre, Development
NOVARTIS
Judit Magos
Clinical Operations Manager
Clinical Operations Manager
IDORSIA
Richard Bobek
Associate Director, Clinical Data Science
Associate Director, Clinical Data Science
MSD
Stephan Cichos
Strategic Project Leader, Clinical Data Strategy & Operations
Strategic Project Leader, Clinical Data Strategy & Operations
BAYER
Luca Finelli
Head of Digital Endpoints & Patient Centred Solutions
Head of Digital Endpoints & Patient Centred Solutions
ROCHE
Sachin Shah
Digital Biomarker Lead
Digital Biomarker Lead
GSK
Andreas Wallnoefer
VC Biotech Advisor
VC Biotech Advisor
Andreas Wallnoefer Life Sciences Consulting
Juliette Guillot
Development ESG Lead, IHI READI Project Lead
Development ESG Lead, IHI READI Project Lead
NOVARTIS
Nicola Unterecker
Patient Advocate
Patient Advocate
YOUTH CANCER EUROPE
Yovanna Castro
Principal Data Scientist, Patient Centered Outcome Research
Principal Data Scientist, Patient Centered Outcome Research
ROCHE
Vera Gomes
President
President
Associação Crohn Colite Portugal
Mark Duman
Patient Engagement Pioneer
Patient Engagement Pioneer
MD HEALTHCARE
Cristina Durán
President
President
EVINOVA
Marc Jones
Chief Executive Officer
Chief Executive Officer
ALTOIDA
Adam Petrich
Chief Medical Officer
Chief Medical Officer
QUANTHEALTH
Marta Carrasco
Biomedical Data Insights Development Leader
Biomedical Data Insights Development Leader
ROCHE
CoNFERENCE SCHEDULE
26 June 2025
08:30
Welcome Introduction
Ernst Jan Bos, Global Medical Director, Roche
08:35
Opening Remarks
Luca Finelli, Head of Digital Endpoints & Patient Centred Solutions, Roche
CONTENT BLOCK 1
INDUSTRY TRENDS AND INNOVATIONS
08:45
FIRESIDE EXPERT KICK-OFF
Industry Trends: Innovations in Clinical Trial Design and Execution
Industry Trends: Innovations in Clinical Trial Design and Execution
• EU Policy: What does it take to make the EU clinical trial landscape more competitive?
• Innovations in Design (AI/ML, Knowledge Management)
• Innovations in Execution (DHTs, Decentralized Trials, and Site Experience)
Isabela Niculae, Head, Clinical Innovation and Digital Solutions, Global Clinical Operations, UCB
Joachim Lövin, Decentralised Clinical Trial (DCT) Specialist, Novo Nordisk
Andreas Wallnoefer, VC Biotech Advisor, Andreas Wallnoefer Life Sciences Consulting
Lorcan Walsh, Head, Digital Endpoint Capability Centre, Development, Novartis
Michelle Longmire, Co-Founder and CEO, Medable
Moderated by: Marco Rafael, Regulatory Science Policy Leader, Roche
09:15
CASE STUDY
Optimizing Drug Development with Actionable Data Insights:
Secondary Use of Data: Multimodal Data Assets
Optimizing Drug Development with Actionable Data Insights:
Secondary Use of Data: Multimodal Data Assets
• Secondary use of data at Roche: leveraging multimodal data assets to give data a new life.
• Optimizing drug development: turning complex data into actionable insights to enhance our study and CDP designs.
Marta Carrasco, Biomedical Data Insights Leader, Roche
09:35
CASE STUDY
Patient Recruitment Enabled through EHRs
Patient Recruitment Enabled through EHRs
Nadir Ammour, Global Lead, Clinical Innovation & External Partnerships, Sanofi
09:55
AI-Driven Trial Simulation: The Art and the Value of the Possible
Adam Petrich, Chief Medical Officer, QuantHealth
10:15
The AI Policy Environment for Medicines Development and Clinical Trials
Thomas Brookland, Lead, European Data and AI Regulatory Policy, Roche
10:35
Networking Break
CONTENT BLOCK 2
Accelerating Patient-Centric Trials
11:00
CASE STUDY
Delivering Better Outcomes through Digital and AI-Enabled Clinical Development
Delivering Better Outcomes through Digital and AI-Enabled Clinical Development
Discover how Evinova's AI platform tackles critical challenges in clinical development, delivering measurable efficiency improvements that accelerate the path from trial to treatment. The session will demonstrate how Evinova's proven clinical technology solutions and deep therapeutic expertise combine to optimize outcomes and ultimately bring innovative medicines to patients faster.
Cristina Durán, President, Evinova
11:20
CASE STUDY
Scaling Clinical Innovation - The Novartis Operating Model for Sustainable Success
Scaling Clinical Innovation - The Novartis Operating Model for Sustainable Success
This session will explore how Novartis’s Clin Ops Innovation team is transforming clinical operations. Discover how their comprehensive operating model scales innovation through a structured framework, ensuring alignment with operational needs and challenges. Learn how they measure success with clear criteria, match specific innovations to operational requirements, and consistently assess the innovation landscape to identify new opportunities. This session will provide valuable insights into Novartis’s systematic approach to driving sustainable, value-driven innovation in clinical trials.
Scott Askin, Portfolio Innovation Director, Global Clinical Operations, Novartis
11:40
Pioneering a New Standard in Cognitive Care, Bridging Human Insight and AI Precision
Marc Jones, CEO, Altoida
12:00
PANEL
Identifying Innovations & Technologies Accelerating Patient-Centric Trials
Identifying Innovations & Technologies Accelerating Patient-Centric Trials
Lauren Sunshine, Director, Product Management, Digital Health, Bristol Myers Squibb
Bola Grace, Senior Director, Digital Biomarkers, Real World Data & Analytics, GSK
Sam Hariry, Global Head, Clinical Innovation, Novartis Institutes for BioMedical Research (NIBR)
Thomas Boillat, Senior Digital Healht Product Lead, Roche
Moderated by: Judit Magos, Clinical Operations Manager, Idorsia
12:25
NETWORKING LUNCH
CONTENT BLOCK 3
Enhancing Diversity in Clinical Trials
13:20
PANEL
Patient Perspectives & Cultural Considerations in Clinical Trials
Patient Perspectives & Cultural Considerations in Clinical Trials
Vera Gomes, President, Associação Crohn Colite Portugal
Nicola Unterecker, Patient Advocate, Youth Cancer Europe
Amri B. Johnson, Founder, Inclusion Wins
Yovanna Castro, Principal Data Scientist, Patient Centered Outcome Research, Roche
Moderated by: Steve Bourke, Founder, PersonalPulse
13:45
CASE STUDY
End to End Inclusive Research
End to End Inclusive Research
What can early stage development bring to late stage development?
Thierry Lave, R&D Academy and Faculty Lead, Roche
14:00
CASE STUDY
IHI READI
IHI READI
This session will explore the collaboration behind the IHI-funded project - IHI READI - aimed at fostering a more cohesive and integrated clinical studies ecosystem for underserved (US) and underrepresented (UR) communities.
Lea Proulx, Patient Voice Partner, Roche
Juliette Guillot, Development ESG Lead, IHI READI Project Lead, Novartis
14:20
CASE STUDY
Technology Fit for Purpose:
Understanding of Potential Issues to Decrease Patient Burden On Your Study
Technology Fit for Purpose:
Understanding of Potential Issues to Decrease Patient Burden On Your Study
Stephan Cichos, Strategic Project Leader, Clinical Data Strategy & Operations, Bayer
14:35
CASE STUDY
The Frailty of Diversity: Including Older Adults in Oncology Trials
The Frailty of Diversity: Including Older Adults in Oncology Trials
Sebastian Heinzmann, Global Medical Science Leader (GMSL), Thoracic Oncology, Roche
14:55
NETWORKING BREAK
CONTENT BLOCK 4
IDEAS INTO ACTION
15:20
CASE STUDY
MSD’s In-House Site Selection Application:
Data-Driven Performance Ranking for Optimized Clinical Trials
MSD’s In-House Site Selection Application:
Data-Driven Performance Ranking for Optimized Clinical Trials
Richard Bobek, Associate Director, Clinical Data Science, MSD
15:35
CASE STUDY
Delivering DCT Trials for Scale and Sustainability - A Case Study of Evidence in Practice
Delivering DCT Trials for Scale and Sustainability - A Case Study of Evidence in Practice
Alison Holland, Chief Customer Officer, Medable
15:55
CASE STUDY
Automated Assessment Auditing Across MindMed’s Pivotal Programs
Automated Assessment Auditing Across MindMed’s Pivotal Programs
Dan Karlin, Chief Medical Officer, MindMed
16:10
PATIENT PERSPECTIVE
An (im)Patient Perspective
An (im)Patient Perspective
Mark Duman, Patient Engagement Pioneer, MD Healthcare
16:30
CLOSING PANEL
DHTs in Clinical Trials: Reality Check and Key Takeaways from Patient and Site Interactions
DHTs in Clinical Trials: Reality Check and Key Takeaways from Patient and Site Interactions
Meri Kay Scott, Associate Vice President, Digital Health R&D, Eli Lilly & Company
Sachin Shah, Digital Biomarker Lead, GSK
Matteo Lai, Chief Executive Officer, Empatica
Mark Duman, Patient Engagement Pioneer, MD Healthcare
Moderated by: Suki Balendra, Director of Strategic Partnerships, Paddington Life Sciences, Imperial College Healthcare NHS Trust
16:55
Closing Reflection
Suki Balendra, Director of Strategic Partnerships, Paddington Life Sciences, Imperial College Healthcare NHS Trust
Ernst Jan Bos, Global Medical Director, Roche
17:00 - 18:30
APÉRO & NETWORKING RECEPTION!
2025 Sponsors & Exhibitors
HOST SPONSOR
GOLD SPONSOR
GOLD SPONSOR
GOLD SPONSOR
GOLD SPONSOR
SILVER SPONSOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
SUPPORTING SPONSOR
SUPPORTING SPONSOR
SUPPORTING SPONSOR
Interested in Sponsorship or
Exhibition Opportunities?
Exhibition Opportunities?
Conference Venue
Roche Tower (Building 1)
The Clinical Trials Innovation Summit (26 June) and the Digital Biomarkers Summit (25 June) will both be held in the Auditorium of Building 1 on the Roche campus in Basel.
Address:
Roche Tower (Building 1)
Grenzacherstrasse 124
4070 Basel, Switzerland
About: The office high-rise, Building 1, is a key pillar of Roche's site development strategy. With its straightforward yet unmistakable design, it blends in perfectly with the Roche grounds and the Basel cityscape. With 41 floors and workspace for around 2,000 employees, the office high-rise also shows a clear commitment to the Basel site.
Address:
Roche Tower (Building 1)
Grenzacherstrasse 124
4070 Basel, Switzerland
About: The office high-rise, Building 1, is a key pillar of Roche's site development strategy. With its straightforward yet unmistakable design, it blends in perfectly with the Roche grounds and the Basel cityscape. With 41 floors and workspace for around 2,000 employees, the office high-rise also shows a clear commitment to the Basel site.
Hotel Room Block
Hyperion Hotel Basel
(4 Star Hotel) Hyperion Hotel Basel in Basel, Switzerland
Location: Messepl. 12, 4058 Basel, Switzerland
In Basel's tallest habitable building, the HYPERION Hotel Basel is next to the Basel Messe trade fair center and just a short walk from the Old Town. It offers a sauna and a fitness center. Each of the 224 non-smoking guest rooms offers panoramic views of the city, free WiFi, air conditioning, refreshing bath products, a safe, hair dryer, and flat-screen TV with Sky channels.
PanAgora Pharma has a conference room block at the Hyperion Hotel Basel - just 1km from Roche Building 1. To book your room at the preferred room block rate, please use this link: CTIS Room Block at Hyperion Hotel Basel
UPDATE: The PanAgora Room Block is now sold out for 2025, but you can still use the link above to make a reservation at the Hyperion Hotel Basel.
